Quinapril long-term benefits after coronary intervention

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1437, 2004-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of glycoprotein IIb/IIIa receptor antagonists in percutaneous coronary intervention results in both short- and long-term benefits

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 10, 2004-10 ,pp. : 7-10

Adis International

Access to resources Recommend Favorite

Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention

By Heeg Bart M.S.  

PharmacoEconomics, Vol. 25, Iss. 9, 2007-01 ,pp. : 769-782

Adis International

Access to resources Recommend Favorite

The Influence of Complete Coronary Revascularization on Long-term Outcomes in Patients with Multivessel Coronary Heart Disease Undergoing Successful Percutaneous Coronary Intervention

By Yang HH   Chen Y   Gao CY  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1106-1112

Field House Publishing

Access to resources Recommend Favorite

Verteporfin: long-term benefits seen in AMD

By  

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Atomoxetine: long-term treatment benefits in ADHD

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite